
    
      Eligible mothers will be randomized (1:1) to either TDF-treated group or untreated group with
      about 100 subjects in each arm. The treatment group will receive TDF starting at week 30-32
      of gestation until week 4 postpartum; follow up will continue until post-partum week 28 and
      infants age of 28 weeks. Untreated group will receive the standard of care with similar
      follow-up schedule as the treatment group.
    
  